Viewing Study NCT03328104

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-05-28 @ 10:00 AM
Study NCT ID: NCT03328104
Status: COMPLETED
Last Update Posted: 2023-07-21
First Post: 2017-10-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
Sponsor: Emory University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoblastic Leukemia View
None Lymphoblastic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T- cell acute lymphoblastic leukemia View
None T-ALL View
None T-cell lymphoblastic lymphoma View
None T-LLy View
None Everolimus View
None Maximum tolerated dose View